Home

forte Obrigatório A pé mata acs med Mathis dignidade arco

Discovery of Imidazole-Based Inhibitors of Plasmodium falciparum  cGMP-Dependent Protein Kinase | ACS Medicinal Chemistry Letters
Discovery of Imidazole-Based Inhibitors of Plasmodium falciparum cGMP-Dependent Protein Kinase | ACS Medicinal Chemistry Letters

Structure–Activity Relationships of (+)-Naltrexone-Inspired Toll-like  Receptor 4 (TLR4) Antagonists | Journal of Medicinal Chemistry
Structure–Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists | Journal of Medicinal Chemistry

Design and Synthesis of Potent Quinazolines as Selective  β-Glucocerebrosidase Modulators | Journal of Medicinal Chemistry
Design and Synthesis of Potent Quinazolines as Selective β-Glucocerebrosidase Modulators | Journal of Medicinal Chemistry

Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting  Blood-Stage Antimalarial with a High Barrier to Resistance and Potential  for Single-Dose Cures in Uncomplicated Malaria | Journal of Medicinal  Chemistry
Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria | Journal of Medicinal Chemistry

Discovery of APD371: Identification of a Highly Potent and Selective CB2  Agonist for the Treatment of Chronic Pain | ACS Medicinal Chemistry Letters
Discovery of APD371: Identification of a Highly Potent and Selective CB2 Agonist for the Treatment of Chronic Pain | ACS Medicinal Chemistry Letters

ACS Medicinal Chemistry Letters | Vol 11, No 11
ACS Medicinal Chemistry Letters | Vol 11, No 11

Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a  Preclinical Candidate for the Treatment of Visceral Leishmaniasis | Journal  of Medicinal Chemistry
Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis | Journal of Medicinal Chemistry

Synthesis and Cell-Based Activity of a Potent and Selective Protein  Tyrosine Phosphatase 1B Inhibitor Prodrug | Journal of Medicinal Chemistry
Synthesis and Cell-Based Activity of a Potent and Selective Protein Tyrosine Phosphatase 1B Inhibitor Prodrug | Journal of Medicinal Chemistry

Forging Odd-Membered Rings: Palladium-Catalyzed Asymmetric Cycloadditions  of Trimethylenemethane | Accounts of Chemical Research
Forging Odd-Membered Rings: Palladium-Catalyzed Asymmetric Cycloadditions of Trimethylenemethane | Accounts of Chemical Research

Structure and Mechanism-Guided Design of Dual Serine/Metallo-Carbapenemase  Inhibitors | Journal of Medicinal Chemistry
Structure and Mechanism-Guided Design of Dual Serine/Metallo-Carbapenemase Inhibitors | Journal of Medicinal Chemistry

Design, Synthesis, and Structure–Activity Relationship Optimization of  Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ)  | Journal of Medicinal Chemistry
Design, Synthesis, and Structure–Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ) | Journal of Medicinal Chemistry

Small Molecules Promote Selective Denaturation and Degradation of Tubulin  Heterodimers through a Low-Barrier Hydrogen Bond | Journal of Medicinal  Chemistry
Small Molecules Promote Selective Denaturation and Degradation of Tubulin Heterodimers through a Low-Barrier Hydrogen Bond | Journal of Medicinal Chemistry

Stabilization of Nanoparticles Produced by Hydrogenation of  Palladium–N-Heterocyclic Carbene Complexes on the Surface of Graphene and  Implications in Catalysis | ACS Omega
Stabilization of Nanoparticles Produced by Hydrogenation of Palladium–N-Heterocyclic Carbene Complexes on the Surface of Graphene and Implications in Catalysis | ACS Omega

Dehydrozingerone Inspired Styryl Hydrazine Thiazole Hybrids as Promising  Class of Antimycobacterial Agents | ACS Medicinal Chemistry Letters
Dehydrozingerone Inspired Styryl Hydrazine Thiazole Hybrids as Promising Class of Antimycobacterial Agents | ACS Medicinal Chemistry Letters

Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide  3-Kinase (PI3K)-γ Inhibitors | Journal of Medicinal Chemistry
Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ Inhibitors | Journal of Medicinal Chemistry

In Search of the Optimal Macrocyclization Site for Neurotensin | ACS  Medicinal Chemistry Letters
In Search of the Optimal Macrocyclization Site for Neurotensin | ACS Medicinal Chemistry Letters

Structure-Guided Modification of Heterocyclic Antagonists of the P2Y14  Receptor | Journal of Medicinal Chemistry
Structure-Guided Modification of Heterocyclic Antagonists of the P2Y14 Receptor | Journal of Medicinal Chemistry

Synthesis of Thymoquinone–Artemisinin Hybrids: New Potent Antileukemia,  Antiviral, and Antimalarial Agents | ACS Medicinal Chemistry Letters
Synthesis of Thymoquinone–Artemisinin Hybrids: New Potent Antileukemia, Antiviral, and Antimalarial Agents | ACS Medicinal Chemistry Letters

Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and  Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain  Kinase Activity | Journal of Medicinal Chemistry
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity | Journal of Medicinal Chemistry

Journal of Natural Products Special Issue Honors Drs. Rachel Mata and  Barbara N. Timmermann - ACS Axial | ACS Publications
Journal of Natural Products Special Issue Honors Drs. Rachel Mata and Barbara N. Timmermann - ACS Axial | ACS Publications

LogD Contributions of Substituents Commonly Used in Medicinal Chemistry |  ACS Medicinal Chemistry Letters
LogD Contributions of Substituents Commonly Used in Medicinal Chemistry | ACS Medicinal Chemistry Letters

Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or  β2i Subunits | Journal of Medicinal Chemistry
Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits | Journal of Medicinal Chemistry

Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor  (IPI-549) as an Immuno-Oncology Clinical Candidate | ACS Medicinal  Chemistry Letters
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate | ACS Medicinal Chemistry Letters

Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ  Inhibitors | ACS Medicinal Chemistry Letters
Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors | ACS Medicinal Chemistry Letters